BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 8753854)

  • 1. Peptide binding characteristics of the coeliac disease-associated DQ(alpha1*0501, beta1*0201) molecule.
    van de Wal Y; Kooy YM; Drijfhout JW; Amons R; Koning F
    Immunogenetics; 1996; 44(4):246-53. PubMed ID: 8753854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both alpha and beta chain polymorphisms determine the specificity of the disease-associated HLA-DQ2 molecules, with beta chain residues being most influential.
    Johansen BH; Jensen T; Thorpe CJ; Vartdal F; Thorsby E; Sollid LM
    Immunogenetics; 1996; 45(2):142-50. PubMed ID: 8952964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule.
    Vartdal F; Johansen BH; Friede T; Thorpe CJ; Stevanović S; Eriksen JE; Sletten K; Thorsby E; Rammensee HG; Sollid LM
    Eur J Immunol; 1996 Nov; 26(11):2764-72. PubMed ID: 8921967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule.
    van de Wal Y; Kooy YM; Drijfhout JW; Amons R; Papadopoulos GK; Koning F
    Immunogenetics; 1997; 46(6):484-92. PubMed ID: 9321428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling of HLA-DQ2 and its interaction with gluten peptides to explain molecular recognition in celiac disease.
    Costantini S; Rossi M; Colonna G; Facchiano AM
    J Mol Graph Model; 2005 Apr; 23(5):419-31. PubMed ID: 15781184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refining the rules of gliadin T cell epitope binding to the disease-associated DQ2 molecule in celiac disease: importance of proline spacing and glutamine deamidation.
    Qiao SW; Bergseng E; Molberg O; Jung G; Fleckenstein B; Sollid LM
    J Immunol; 2005 Jul; 175(1):254-61. PubMed ID: 15972656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes.
    Moustakas AK; van de Wal Y; Routsias J; Kooy YM; van Veelen P; Drijfhout JW; Koning F; Papadopoulos GK
    Int Immunol; 2000 Aug; 12(8):1157-66. PubMed ID: 10917890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of eluted peptide sequence data to identify the binding characteristics of peptides to the insulin-dependent diabetes susceptibility allele HLA-DQ8 (DQ 3.2).
    Godkin A; Friede T; Davenport M; Stevanovic S; Willis A; Jewell D; Hill A; Rammensee HG
    Int Immunol; 1997 Jun; 9(6):905-11. PubMed ID: 9199974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA binding and T cell recognition of a tissue transglutaminase-modified gliadin epitope.
    Quarsten H; Molberg O; Fugger L; McAdam SN; Sollid LM
    Eur J Immunol; 1999 Aug; 29(8):2506-14. PubMed ID: 10458765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and evaluation of high-affinity binders for the celiac disease associated HLA-DQ2 molecule.
    Kapoerchan VV; Wiesner M; Hillaert U; Drijfhout JW; Overhand M; Alard P; van der Marel GA; Overkleeft HS; Koning F
    Mol Immunol; 2010 Feb; 47(5):1091-7. PubMed ID: 19962195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires.
    Bergseng E; Dørum S; Arntzen MØ; Nielsen M; Nygård S; Buus S; de Souza GA; Sollid LM
    Immunogenetics; 2015 Feb; 67(2):73-84. PubMed ID: 25502872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease.
    Tollefsen S; Arentz-Hansen H; Fleckenstein B; Molberg O; Ráki M; Kwok WW; Jung G; Lundin KE; Sollid LM
    J Clin Invest; 2006 Aug; 116(8):2226-36. PubMed ID: 16878175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of peptides from the N-terminal region of alpha-gliadin to the celiac disease-associated HLA-DQ2 molecule assessed in biochemical and T cell assays.
    Johansen BH; Gjertsen HA; Vartdal F; Buus S; Thorsby E; Lundin KE; Sollid LM
    Clin Immunol Immunopathol; 1996 Jun; 79(3):288-93. PubMed ID: 8635288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human genome search in celiac disease: mutated gliadin T-cell-like epitope in two human proteins promotes T-cell activation.
    Kumar R; Eastwood AL; Brown ML; Laurie GW
    J Mol Biol; 2002 Jun; 319(3):593-602. PubMed ID: 12054857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale characterization of natural ligands explains the unique gluten-binding properties of HLA-DQ2.
    Stepniak D; Wiesner M; de Ru AH; Moustakas AK; Drijfhout JW; Papadopoulos GK; van Veelen PA; Koning F
    J Immunol; 2008 Mar; 180(5):3268-78. PubMed ID: 18292551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An insertion mutant in DQA1*0501 restores susceptibility to HLA-DM: implications for disease associations.
    Hou T; Macmillan H; Chen Z; Keech CL; Jin X; Sidney J; Strohman M; Yoon T; Mellins ED
    J Immunol; 2011 Sep; 187(5):2442-52. PubMed ID: 21775680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Main chain hydrogen bond interactions in the binding of proline-rich gluten peptides to the celiac disease-associated HLA-DQ2 molecule.
    Bergseng E; Xia J; Kim CY; Khosla C; Sollid LM
    J Biol Chem; 2005 Jun; 280(23):21791-6. PubMed ID: 15826953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DQ2-restricted T-cell recognition of gluten-derived peptides in celiac disease. Influence of amino acid substitutions in the membrane distal domain of DQ beta 1*0201.
    Paulsen G; Lundin KE; Gjertsen HA; Hansen T; Sollid LM; Thorsby E
    Hum Immunol; 1995 Feb; 42(2):145-53. PubMed ID: 7744618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominance of an alternative CLIP sequence in the celiac disease associated HLA-DQ2 molecule.
    Wiesner M; Stepniak D; de Ru AH; Moustakis AK; Drijfhout JW; Papadopoulos GK; van Veelen PA; Koning F
    Immunogenetics; 2008 Sep; 60(9):551-5. PubMed ID: 18584168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling the structural basis for the unusually rich association of human leukocyte antigen DQ2.5 with class-II-associated invariant chain peptides.
    Nguyen TB; Jayaraman P; Bergseng E; Madhusudhan MS; Kim CY; Sollid LM
    J Biol Chem; 2017 Jun; 292(22):9218-9228. PubMed ID: 28364043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.